INOGEN, INC. Payments to Acquire Available-for-sale Securities
INOGEN, INC. (INGN) reported Payments to Acquire Available-for-sale Securities of $50.28 million for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-06.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAvailableForSaleSecurities · last filed 2018-11-06
- INOGEN, INC. payments to acquire available-for-sale securities for the quarter ending 2018-09-30 was $10.97M, a 13.20% decline year-over-year.
- INOGEN, INC. payments to acquire available-for-sale securities for the quarter ending 2018-06-30 was $27.75M, a 117.85% increase year-over-year.
- INOGEN, INC. payments to acquire available-for-sale securities for the quarter ending 2018-03-31 was $11.56M, a 15.79% increase year-over-year.
- INOGEN, INC. payments to acquire available-for-sale securities for the quarter ending 2017-12-31 was $11.57M, a 69.56% increase year-over-year.
- INOGEN, INC. payments to acquire available-for-sale securities for fiscal 2017 was $46.93M, a 41.61% increase from fiscal 2016.
- INOGEN, INC. payments to acquire available-for-sale securities for fiscal 2016 was $33.14M, a 9.51% decline from fiscal 2015.
- INOGEN, INC. payments to acquire available-for-sale securities for fiscal 2015 was $36.63M.
| Period end | Payments to Acquire Available-for-sale Securities 3 month | Payments to Acquire Available-for-sale Securities 6 month | Payments to Acquire Available-for-sale Securities 9 month | Payments to Acquire Available-for-sale Securities 12 month |
|---|---|---|---|---|
| 2018-09-30 | $10.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $38.72M derived: sum of 2 quarters · filed 2018-11-06 | $50.28M 10-Q · filed 2018-11-06 | $61.85M derived: sum of 4 quarters · filed 2018-11-06 |
| 2018-06-30 | $27.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $39.31M 10-Q · filed 2018-08-07 | $50.88M derived: sum of 3 quarters · filed 2018-08-07 | $63.52M derived: sum of 4 quarters · filed 2018-11-06 |
| 2018-03-31 | $11.56M 10-Q · filed 2018-04-30 | $23.13M derived: sum of 2 quarters · filed 2018-04-30 | $35.77M derived: sum of 3 quarters · filed 2018-11-06 | $48.51M derived: sum of 4 quarters · filed 2018-11-06 |
| 2017-12-31 | $11.57M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $24.21M derived: sum of 2 quarters · filed 2018-11-06 | $36.95M derived: sum of 3 quarters · filed 2018-11-06 | $46.93M 10-K · filed 2018-02-27 |
| 2017-09-30 | $12.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $25.38M derived: sum of 2 quarters · filed 2018-11-06 | $35.37M 10-Q · filed 2018-11-06 | $42.19M derived: sum of 4 quarters · filed 2018-11-06 |
| 2017-06-30 | $12.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $22.73M 10-Q · filed 2018-08-07 | $29.55M derived: sum of 3 quarters · filed 2018-08-07 | $41.01M derived: sum of 4 quarters · filed 2018-08-07 |
| 2017-03-31 | $9.99M 10-Q · filed 2018-04-30 | $16.81M derived: sum of 2 quarters · filed 2018-04-30 | $28.27M derived: sum of 3 quarters · filed 2018-04-30 | $36.14M derived: sum of 4 quarters · filed 2018-04-30 |
| 2016-12-31 | $6.82M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $18.29M derived: sum of 2 quarters · filed 2018-02-27 | $26.15M derived: sum of 3 quarters · filed 2018-02-27 | $33.14M 10-K · filed 2018-02-27 |
| 2016-09-30 | $11.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $19.33M derived: sum of 2 quarters · filed 2017-11-07 | $26.32M 10-Q · filed 2017-11-07 | $29.39M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $7.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $14.86M 10-Q · filed 2017-08-03 | $17.93M derived: sum of 3 quarters · filed 2018-02-27 | $30.93M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $6.99M 10-Q · filed 2017-05-09 | $10.06M derived: sum of 2 quarters · filed 2018-02-27 | $23.06M derived: sum of 3 quarters · filed 2018-02-27 | |
| 2015-12-31 | $3.07M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $16.07M derived: sum of 2 quarters · filed 2018-02-27 | $36.63M 10-K · filed 2018-02-27 | |
| 2015-09-30 | $13.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $33.56M 10-Q · filed 2016-11-03 | ||
| 2015-06-30 | $20.56M 10-Q · filed 2016-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| ENvue Medical, Inc. (FEED) | United States | $0.011B |